Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum - PubMed (original) (raw)

Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum

Lamees A BenSaad et al. BMC Complement Altern Med. 2017.

Abstract

Background: Punica granatum (pomegranate), an edible fruit originating in the Middle East, has been used as a traditional medicine for treatment of pain and inflammatory conditions such as peptic ulcer. The numerous risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs) for treatment of pain and inflammation give rise to using medicinal herbs as alternative therapies. This study aimed to evaluate the anti-inflammatory effect of isolated compounds from the ethyl acetate (EtOAc) fraction of P. granatum by determination of their inhibitory effects on lipopolysaccharide (LPS), stimulated nitric oxide (NO), prostaglandin E2 (PGE-2), interleukin-6 (IL-6) and cyclooxxgenase-2 (COX-2) release from RAW264.7 cells.

Methods: The compounds ellagic acid, gallic acid and punicalagin A&B were isolated from EtOAc by high performance liquid chromatography (HPLC) and further identified by mass spectrometry (MS). The inhibitory effect of ellagic acid, gallic acid and punicalagin A&B were evaluated on the production of LPS-induced NO by Griess reagent, PGE-2 and IL-6 by immunoassay kit and prostaglandin E2 competitive ELISA kit, and COX-2 by Western blotting.

Results: Ellagic acid, gallic acid and punicalagin A&B potentially inhibited LPS-induced NO, PGE-2 and IL-6 production.

Conclusion: The results indicate that ellagic acid, gallic acid and punicalagin may be the compounds responsible for the anti-inflammatory potential of P. granatum.

Keywords: Cytokines; Cytotoxicity; Ellagic acid; Gallic acid; Inflammation; Punica granatum; Punicalagin.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

HPLC chromatogram of ethyl acetate fraction showing the presence of punicalagin A&B collected at 14.1 min

Fig. 2

Fig. 2

HPLC chromatogram of ethyl acetate fraction showing the presence of ellagic acid collected at 22.6 min

Fig. 3

Fig. 3

Mass spectrum showing the presence of punicalagin A&B [M-H] -m/z 1083.43

Fig. 4

Fig. 4

Mass spectrum showing the presence of ellagic acid [M-H] -m/z 301

Fig. 5

Fig. 5

Cell viability was determined from the 24 h culture of cells stimulated with LPS (1 μg/mL) in the presence of ellagic acid, gallic acid and punicalagin The data represent mean ± SD of n = 3, *p < 0.05,**p < 0.01 vs LPS treated control

Fig. 6

Fig. 6

Effect of ellagic acid, gallic acid and punicalagin on nitrite production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 μg/mL of LPS only or with LPS plus various concentrations (50, 100, 150, 200 μg/mL) of gallic acid for 24 h. Nitrite production was determined by the Griess reagent method. The data represent the mean ± SD of n = 3, *** p < 0.001, vs #LPS treated control* means significant difference by Tukey Kramer test

Fig. 7

Fig. 7

Effect of ellagic acid, gallic acid and punicalagin on PGE-2 production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 μg/ml of LPS only or with LPS plus various concentrations (50, 100, 150, 200 μg/mL) of ellagic acid, gallic acid and punicalagin n = 3, ***p < 0.001 vs #LPS treated control* means significant difference by Tukey Kramer test

Fig. 8

Fig. 8

Effect of ellagic acid, gallic acid and punicalagin on IL-6 production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 μg/ml of LPS only or with LPS plus various concentrations (50, 100, 150, 200 μg/mL) of for ellagic acid, gallic acid and punicalagin 6 h. IL-6 produced and released into the culture medium was assayed by ELISA method. The data represent the mean ± SD of n = 3, *** p < 0.001 vs #LPS treated control* means significant difference by Tukey Kramer test

Fig. 9

Fig. 9

Effect of ellagic acid, gallic acid and punicalagin on the activation of COX-2 in the LPS-stimulated RAW264.7 cells. RAW264.7 cells were stimulated with LPS (1 μg/mL) in ellagic acid, gallic acid and punicalagin A&B (50, 100, 150, 200 μg/mL) for 24 h. Whole-cell lysates were subjected to 10% SDS-PAGE and expression of COX-2 and β-actin were determined by western blotting. Band intensities were expressed as relative density compared to LPS control. The figure is representative of three similar experiments

Similar articles

Cited by

References

    1. Gautam R, Jachak SM. Recent developments in antiinflammatory natural products. Med Res Rev. 2009;29(5):767–820. doi: 10.1002/med.20156. - DOI - PubMed
    1. Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Int J Interferon Cytokine Mediator Res. 2011;3:19–27. doi: 10.2147/IJICMR.S10200. - DOI
    1. Olapour S, Najafzedeh H. Evaluation analgesic, anti-inflammatory and antiepletic effect of hydro alcoholic peel extract of Punica granatum (pomegranate) Asian J Med Sci. 2010;2(6):266–270.
    1. Ouachrif A, Khalki H, Chaib S, Muntassir M, Abufatima R, Farouk L, Benharraf A, Chait A. Comparitive study of the anti-inflammatory and antinociceptive effects of two varieties of Punicagranatum. Pharm Biol. 2012;50(4):429–438. doi: 10.3109/13880209.2011.611142. - DOI - PubMed
    1. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) prefentially inhibit COX-2activity exvivo and IL-I beta induced PGE2 production in human chondrocytes in vitro. J Inflammation. 2008;5:9. doi: 10.1186/1476-9255-5-9. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources